Alternatives to Czechia – Pharmaceutical products – Léčivý přípravek s účinnou látkou CEFAZOLIN

Czechia – Magnetic resonance unit – Magnetická rezonance

Czechia – Analgesics – Fremanezumab

Czechia – Medical consumables – Dodávky dialyzačních roztoků a spotřebního materiálu k přístroji multiFiltrate (PRO) a multifiltrate CiCa

Czechia – Diagnostic devices – Zajištění diagnostik pro imunoanalytické stanovení autoprotilátek - UKIA

Czechia – Medical consumables – Spotřební materiál pro hematologické analyzátory včetně výpůjčky

Czechia – Beds for medical use – Nákup 42 ks lůžek s laterálním náklonem, 81 ks lůžek polohovacích a 120 ks nočních stolků

Czechia – Devices and instruments for infusion – Infuzní technika a s ní spojený spotřební materiál pro oddělení ARO a NIP VN Olomouc 2026

Czechia – Artificial joints – Individuální onkologické implantáty

Expected Outcome: the proposals under this call are expected to address one or more of the following subjects : • Enhanced personalized monitoring, care and treatments, focusing on the development of highly customized healthcare solutions, including the required research and diagnostic tools, tailored to individual needs, covering various scenarios such as chronic disease management, physiotherapy, precision diagnosis, personalized medicine/treatment, pre- and postoperative care, and daily assistance in homes and common spaces. It also targets effective management of chronic diseases and elderly care through personalized monitoring and interventions facilitated by advanced sensor technologies and edge-to-cloud solutions. This includes the development and integration of solutions for Hospitalization at Home, enabling patients to receive complex, remotely supervised care using intelligent medical devices capable of sensing, analysing, and transmitting real-time data. This requires a continuum, from in-hospital diagnostics to robust, long-term patient support at home via AI-driven care pathways and hospitalization at home. • Prevention and treatment of diseases, allowing the improved…

Expected Outcome: Proposals submitted to this call are expected to address several of the following elements: • Scaling of wafer-level photonic processes for key materials (e.g. SiN, InP, GaAs),including process integration, yield optimisation, and manufacturability at highvolumes. • Development of packaging and test solutions that are scalable, automated, andcompatible with co-packaged optics and advanced photonic-electronic integration. • Integration of heterogeneous materials and components, such as on-chip lasers,modulators, and detectors, using advanced packaging and assembly approaches. • Design-process-equipment co-optimisation, enabling repeatable, cost-effectiveproduction of complex photonic circuits and systems, including use of PDKs andvalidated building blocks. • Demonstration of system-level functionality through application-relevant use casesin strategic sectors (e.g. AI, sensing, telecommunication, mobility, health, defence),with quantified performance metrics and clear market relevance.

Provision of Non-Emergency Patient Transport Services (NEPTS) for GHFT. Additional information: GHFT (Gloucestershire Hospitals NHS Foundation Trust) "the Authority" invites Bidders to compete for the Provision of Non-Emergency Patient Transport Services (NEPTS) for GHFT. This procurement is being undertaken Provider Selection Regime which came into force on 1 January 2024. This Tender is only open all suppliers The Tender information can be found on the Trusts e-Portal (Atamis Health Family) at https://health-family.force.com/s/Welcome. Reference - C457853 You must be registered on the Atamis to view the Documents and all bids and communications must be submitted via this e-Portal. If you require any technical assistance using Atamis, please refer to the Supplier Portal user guide ( https://services.atamis.co.uk/docs/Supplier_User_Guide.pdf ) and/or the helpdesk on 0800 0988 201.

Sweden – Personal care products – Extern Remiss Hygien och städmaterial 2025